Portfolio company
DVS Sciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops mass cytometry and microfluidics technologies for biomedical researchers to study health and disease and create new medicines.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
LUMICKS
This company develops single-molecule and cell avidity analysis instruments for academic researchers and pharmaceutical companies to study biological mechanisms and develop life-saving therapies.
Nanocellect Biomedical
This company develops microfluidic cell sorting instruments and consumables for biomedical researchers in drug discovery, genomics and cell line development.
Zephyrus Biosciences
This company develops single-cell protein analysis instruments and research tools for academic, biopharmaceutical and clinical scientists conducting disease research.
Standardbiotools
This company develops genomic and proteomic analytical instruments and consumables for life sciences researchers focused on human health breakthroughs.
Dropworks
This company develops digital PCR instruments for highly sensitive nucleic acid quantification for life science and diagnostic researchers.
Atrandi Biosciences
This company develops single-cell analysis platforms and microfluidic technologies for life science researchers in genomics, screening and biological innovation.
Cellular Research
This company develops single-cell genetic analysis tools for academic and industrial researchers to quantify gene expression in individual cells.